Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible.
Thinzar M LwinMichael A TurnerSiamak AmirfakhriHiroto NishinoRobert M HoffmanMichael BouvetPublished in: Cells (2022)
Colorectal cancer (CRC) is a common cause of cancer and cancer-related death. Surgery is the only curative modality. Fluorescence-enhanced visualization of CRC with targeted fluorescent probes that can delineate boundaries and target tumor-specific biomarkers can increase rates of curative resection. Approaches to enhancing visualization of the tumor-to-normal tissue interface are active areas of investigation. Nonspecific dyes are the most-used approach, but tumor-specific targeting agents are progressing in clinical trials. The present narrative review describes the principles of fluorescence targeting of CRC for diagnosis and fluorescence-guided surgery with molecular biomarkers for preclinical or clinical evaluation.
Keyphrases
- single molecule
- cancer therapy
- minimally invasive
- clinical trial
- energy transfer
- clinical evaluation
- living cells
- coronary artery bypass
- small molecule
- papillary thyroid
- quantum dots
- squamous cell carcinoma
- drug delivery
- prognostic factors
- coronary artery disease
- surgical site infection
- percutaneous coronary intervention
- label free
- bone marrow
- fluorescent probe
- open label
- fluorescence imaging
- study protocol